Atul Pathak (16 results)

PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.

Taschenbuch. Condition: Neu. Neuware - DON'T BUY THAT FRANCHISE (UNTIL YOU READ THIS)Before you wire the deposit, read this book.Every year thousands of capable people buy the wrong franchise for the right reasons. The founder was likeable. The brochure looked good. The trade show was convincing. What they never did was read the disclosure document, call a single existing owner, or run the numbers on the one location they would actually own.They rarely fail because they lack talent or effort. They fail because they chose badly, with incomplete information, under pressure from someone who was paid to close them.This book is the process that prevents that.Drawing on twenty years of guiding first time buyers through this decision, senior franchise consultant Atul Pathak turns franchise diligence into something you can follow step by step. Every chapter ends with a checklist or a worksheet, so by the last page you hold a personal readiness profile, a real budget, a scoring system for your shortlist, and a 90 day action plan with a decision gate at every stage.Inside you will learn how to: - Score your own readiness honestly, before you spend a dollar- Understand how franchising actually works: royalties, territories, terms, and what the franchisor genuinely owes you- Build a real budget covering the franchise fee, build out, working capital, and the reserves most buyers forget- Read a Franchise Disclosure Document without a law degree, and know which items matter most- Ask franchisors the questions they quietly hope you will skip- Run validation calls with current and former owners, and hear what they are really telling you- Compare SBA lending, ROBS, and self funding without guesswork- Recognize the mistakes that quietly sink new owners in year two- Execute a 90 day roadmap from first inquiry to signed agreementWho this book is forCorporate professionals planning an exit. Immigrants and families building something durable in a new country. Couples investing together. Investors adding an operating business to a portfolio. Anyone who has typed 'franchises for sale' into a search bar late at night and wondered whether it could really work.Franchising is not the right path for everyone, and this book says so plainly. What it promises is that you will know which one you are, and why, with reasons you can point to.You are not buying a brand. You are buying a system, a relationship, and a decade of your working life. Choose accordingly.Start with Chapter 1. Ninety days from now you will either hold a franchise agreement you trust, or the certain knowledge of what to prepare before you try again. Both are worth more than a deposit you cannot get back.Educational content only. Not legal, financial, or investment advice. Always review the Franchise Disclosure Document with a qualified attorney and accountant before committing funds. …

Condition: New. pp. 156.

Taschenbuch. Condition: Neu. Cationic Polymers based Non-viral Gene Carriers | Pharmaceutical Applications of Nano-vectors in Transfection Technology | Atul Pathak (u. a.) | Taschenbuch | 156 S. | Englisch | 2011 | LAP LAMBERT Academic Publishing | EAN 9783843376198 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.…

Condition: New. Print on Demand.

Paperback. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condition: New. Print on Demand.

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Nucleic acids-based next generation biopharmaceuticals (i.e., oligonucleotides, siRNA) are potential therapeutic agents have ability to cope with various incurable diseases. However, several biological barriers present a challenge for efficient gene delivery. Inception of nanotechnology now offer numerous non-viral vectors that have been fabricated and found capable of transmitting the biopharmaceuticals into the cell and even into specific subcellular compartments like mitochondria. This book illustrates novel chemically modified polyallylamine and polyethylenimine based nano- vectors for enhanced gene delivery. Modification of these polymers using imidazolyl and polysaccharides such as hyaluronic acid, chondroitin sulfate and heparin not only improve cytotoxicity index but also provides site-specificity for cell-type specific gene delivery. Incorporation of targeting moiety minimizes the chance of potential adverse effects and also reduces the amount the amount of dose required to achieve desired therapeutic effects. Recent developments in formulation of efficient drug carriers showed potential to develop gene therapy again diseases like cancer. 156 pp. Englisch.…

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Pathak AtulDr. Atul Pathak is a Research Fellow at Immune Disease Institute, Program and Cellular and Molecular Medicine at Children Hospital, Harvard Medical School, Boston, USA. He earned his Ph.D. in Pharmaceutical Science. D. …

Condition: New. Print on Demand pp. 156 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.

Condition: New. PRINT ON DEMAND pp. 156.

Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Nucleic acids-based next generation biopharmaceuticals (i.e., oligonucleotides, siRNA) are potential therapeutic agents have ability to cope with various incurable diseases. However, several biological barriers present a challenge for efficient gene delivery. Inception of nanotechnology now offer numerous non-viral vectors that have been fabricated and found capable of transmitting the biopharmaceuticals into the cell and even into specific subcellular compartments like mitochondria. This book illustrates novel chemically modified polyallylamine and polyethylenimine based nano- vectors for enhanced gene delivery. Modification of these polymers using imidazolyl and polysaccharides such as hyaluronic acid, chondroitin sulfate and heparin not only improve cytotoxicity index but also provides site-specificity for cell-type specific gene delivery. Incorporation of targeting moiety minimizes the chance of potential adverse effects and also reduces the amount the amount of dose required to achieve desired therapeutic effects. Recent developments in formulation of efficient drug carriers showed potential to develop gene therapy again diseases like cancer.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 156 pp. Englisch.…

Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Nucleic acids-based next generation biopharmaceuticals (i.e., oligonucleotides, siRNA) are potential therapeutic agents have ability to cope with various incurable diseases. However, several biological barriers present a challenge for efficient gene delivery. Inception of nanotechnology now offer numerous non-viral vectors that have been fabricated and found capable of transmitting the biopharmaceuticals into the cell and even into specific subcellular compartments like mitochondria. This book illustrates novel chemically modified polyallylamine and polyethylenimine based nano- vectors for enhanced gene delivery. Modification of these polymers using imidazolyl and polysaccharides such as hyaluronic acid, chondroitin sulfate and heparin not only improve cytotoxicity index but also provides site-specificity for cell-type specific gene delivery. Incorporation of targeting moiety minimizes the chance of potential adverse effects and also reduces the amount the amount of dose required to achieve desired therapeutic effects. Recent developments in formulation of efficient drug carriers showed potential to develop gene therapy again diseases like cancer.…